Table 3.
Adjusted and unadjusted models evaluating the association between place of residence and (A) Disease-free survival and (B) Relapse
A. Disease-free survivalc | |||||
---|---|---|---|---|---|
Main Variable | Unadjusted model | Adjusted for Incomea | Adjusted for Patient, Disease and Tx Charb | Adjusted for Patient, Disease and Tx Char and Incomea,b | |
Urban | 1.00 | 1.00 | 1.00 | 1.00 | |
Rural | 1.06 (0.98–1.14) | 0.97 (0.89–1.05) | 1.05 (0.97–1.14) | 0.99 (0.91–1.07) | |
p=0.15 | p=0.48 | p=0.20 | p=0.76 | ||
B. Relapse | |||||
Main Variable | Unadjusted model | Adjusted for Incomea | Adjusted for Patient, Disease and Tx Charb | Adjusted for Patient, Disease and Tx Char and Incomea,b | |
Urban | 1.00 | 1.00 | 1.00 | 1.00 | |
Rural | 1.04 (0.90–1.18) | 0.98 (0.85–1.13) | 1.02 (0.89–1.16) | 0.97 (0.83–1.12) | |
p=0.61 | p=0.78 | p=0.83 | p=0.66 |
Income entered as quartiles: <$34,700, 34,700–43,600, 46,600–56,300, >$56,300
Adjusted for graft type and cell dose, HLA-match, patient age, disease type, disease stage, number of co-morbidities, CMV donor-recipient match, race/ethnicity, and year of transplant
Model stratified for Karnofsky performance score